5-Bromo-4-fluoro-2,3-dihydro-1H-indol-2-one

Catalog No. :
ACKMIZ104
CAS No. :
1823917-90-3
Molecular Formula :
C8H5BrFNO
Molecular Weight :
230.04

IUPAC Name:5-bromo-4-fluoroindolin-2-one

5-Bromo-4-fluoro-2,3-dihydro-1H-indol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$186.00Login to see priceIn stockInquiry
250mg95%$309.00Login to see priceIn stockInquiry
500mg95%$433.00Login to see priceIn stockInquiry
1g95%$618.00Login to see priceInquiryInquiry
5g95%$1854.00Login to see priceInquiryInquiry
10g95%$3090.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-fluoro-2,3-dihydro-1H-indol-2-one
IUPAC Name5-bromo-4-fluoroindolin-2-one
MDL No.MFCD27664899
Molecular FormulaC8H5BrFNO
Molecular Weight230.04
SMILESO=C1NC2=C(C(F)=C(Br)C=C2)C1
InChI KeyHRXCYGPHPDAXEE-UHFFFAOYSA-N
Synonym5-bromo-4-fluoroindolin-2-one;5-Bromo-4-fluoro-2,3-dihydro-1H-indol-2-one;5-Bromo-4-fluoro-1,3-dihydro-indol-2-one;2H-Indol-2-one, 5-bromo-4-fluoro-1,3-dihydro-;5-Bromo-4-fluoro-1,3-dihydro-2H-indol-2-one
CAS No.1823917-90-3
PubChem CID117209425

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKMIZ104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKMIZ104 route product structure diagram
    ACKMIZ1041823917-90-3 In Stock
Inquiry

2. ACKMIZ104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKMIZ104 route product structure diagram
    ACKMIZ1041823917-90-3 In Stock
Inquiry

Comments (0)